THE TECFIDERA CHANNEL

Tecfidera (Dimethyl Fumarate)

Monday, May 5, 2014

12 HEADLINES FROM TODAYS MS NEWS

 Higher Education Protects MS Patients From Cognitive Decline

At One Month Post-Launch, Over Half of Surveyed U.S. Neurologists Have Prescribed Biogen Idec's Tecfidera, the Third-to-Market Oral Therapy, to Their Multiple Sclerosis PatientsTecfidera's High Early Physician Trial Rate Surpasses that Observed With Novartis's Gilenya and Genzyme's Aubagio, According to a New Report 

Multiple sclerosis patient says cannabis-based drug Sativex ‘changed my life’

PR executive killed herself after taking Multiple Sclerosis drug she found online to treat her alcoholism, inquest told

CNN’s Dr. Sanjay Gupta Profiles BalanceWear® to Resolve Multiple Sclerosis Instability Issues

Evidence of delayed cancer detection in MS patients

Unraveling complex genetic interplay for MS risks

Children's firefly book helps author cope with multiple sclerosis

Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis

Tocopherol Derivative TFA-12 Promotes Myelin Repair in Experimental Models of Multiple Sclerosis

Negative work events and accommodations in employed multiple sclerosis patients

Underlying cause of death in Danish patients with multiple sclerosis: results from the Danish Multiple Sclerosis Registry
Posted by YNergy at 5:05 PM
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Labels: Tecfidera (Dimethyl Fumarate)
Newer Post Older Post Home

Blog Archive

  • ►  2016 (21)
    • ►  June (4)
    • ►  April (17)
  • ►  2015 (15)
    • ►  July (1)
    • ►  May (1)
    • ►  April (2)
    • ►  March (5)
    • ►  February (1)
    • ►  January (5)
  • ▼  2014 (187)
    • ►  June (87)
    • ▼  May (100)
      • What Does a Mixed FDA Verdict Mean for Sanofi's MS...
      • Yvonne Decellis, Columnist & Author, MSnewsChannel...
      • BREAKING NEWS
      • CORRECTED-FDA panel says safety issues do not rule...
      • Biogen’s Tecfidera is top potential moneymaker of ...
      • Breaking News Update: Lemtrada (AKA: Alemtuzumab &...
      • COPAXONE LEADS IN NEW PRESCRIPTIONS
      • Teva facing patent loss of Copaxone & loss of inc...
      • TECFIDERA SUCCEEDS IN PROTECTING BIOGEN'S MS MARKE...
      • TECFIDERA WAS DERIVED FROM AN OLD BASIC CHEMICAL: ...
      • Wednesday's News for MSers: 204 New Stories for yo...
      • Biogen Idec Inc, the maker of MS drugs Avonex, Tys...
      • Tuesday's News for MSers: 194 New Stories for you:...
      • Sales of Biogen's multiple sclerosis pill Tecfider...
      • Monday's News for MSers: 174 New Stories for you: ...
      • Sunday's News for MSers: 165 New Stories for you: ...
      • TECFIDERA RESEARCH REPORT
      • BREAKING NEWS:
      • Friday's News for MSers: 140 New Stories for you: ...
      • A Changing of the Guard in Treating Multiple Scler...
      • sorry: this post was late due to technical problem...
      • Wednesday's News for MSers: 120 New Stories for you
      • Monday's News for MSers: 103 New Stories for you
      • News for MSers: 90 New Stories for you from 10/1 t...
      • BREAKING NEWS
      • Tecfidera & Ampyra Show Potential for Quality of L...
      • GREAT NEWS ON TECFIDERA
      • "Biogen sees 'unlikely' link between Tecfidera and...
      • Kerry Pittmann-Galcik, Columnist:
      • Jeannine Everett, Columnist & Tecfidera Editor
      • Teri's Column: THIS IS MY TECFIDERA STORY! I TRIED...
      • Biogen Idec Dominant Player In Multiple Sclerosis ...
      • TECFIDERA'S SUCCESS HAS PROMPTED A MAJOR SHIFT IN ...
      • Jeannine Everett, Columnist & Tecfidera Editor: MY...
      • Analysts increase sales estimates for Biogen’s new...
      • Biogen Says Death of MS Patient Not Related to Dru...
      • Biogen Says Death of MS Patient Not Related to Dru...
      • 18 STUDIES IN TODAY'S NEWS FOR NEUROLOGISTS & SAAV...
      • For Facebook (Terri) ECTRIMS PARTIAL
      • Cindi Hopper, Columnist, MSnewsChannel.com: MY COL...
      • "Tecfidera's gain is Teva's pain! Is Biogen Idec ...
      • Teva has won another battle in the war to defend m...
      • ECTRIMS Congress 2013: Biogen covers all bases for...
      • ECTRIMS Congress 2013: Biogen Idec's new multiple ...
      • ECTRIMS Congress 2013: New TECFIDERA Data Show Sus...
      • Monthly Recap: WE POSTED THESE 556 STUDIES & ARTIC...
      • Im not taking any Multiple Sclerosis meds! I'm get...
      • WEEKEND RECAP: HERE'S THE 146 ARTICLES & STUDIES W...
      • Judy Kazakawich, Columnist: Tecdifera has helped m...
      • 19 Articles for Neurologists: Friday
      • 10 Articles for Patients: Thursday September 25th
      • Jeannine Everett, Columnist & News Editor: MY COLU...
      • POST: Judi Kazakowich, Columnist: "Tecfidera has d...
      • NYT: Patients fear drug cost spikes under health l...
      • The Tecfidera $10 Co-pay Program: you pay just $10...
      • SUNDAY RECAP: HERE'S THE 128 ARTICLES & STUDIES WE...
      • Yvonne Decelis, Columnist: MY TECFIDERA DIARY: MY ...
      • Kerry Galcik, Columnist, MSnewsChannel.com: THIS I...
      • SUNDAY RECAP: HERE'S THE 121 ARTICLES & STUDIES WE...
      • 21 ARTICLES & STUDIES IN SATURDAY'S NEWS FOR NEURO...
      • 15 ARTICLES & STUDIES IN FRIDAY'S NEWS FOR NEUROLO...
      • JEANNINE'S COLUMN:* My first & last visit to the n...
      • NEUROLOGY CONVENTION IN LAS VEGAS: GREAT REPORT WI...
      • ECTRIMS UPDATE #2: BIOGEN HAS 3 NEW MS TREATMENTS ...
      • SUNDAY RECAP: WE'VE POSTED 118 ARTICLES & STUDIES ...
      • 12 ARTICLES & STUDIES IN THURSDAY'S NEWS FOR NEURO...
      • Judy Kazakawich, Columnist: TECFIDERA MIRACLES!
      • Yvonne Decellis, Columnist: THE NUMBNESS & PAIN IN...
      • Tecfidera was the best launch in the history of MS...
      • FREE!!! CLICK THE YELLOW LINK BELOW TO RECEIVE A M...
      • KAYLA'S COLUMN: I'm in a bad place in my life & fe...
      • A HISTORY OF PAST...CURRENT & FUTURE MS TREATMENTS...
      • HERE'S 156 STUDIES & ARTICLES WE POSTED FOR YOU IN...
      • MY COLUMN TODAY IS FILLED WITH TECFIDERA TIPS! I t...
      • 31 ARTICLES & STUDIES IN FRIDAY'S NEWS
      • 24 NEW HEADLINES IN FRIDAY'S NEWS: BG-12, OPTIC NE...
      • HERE'S MONDAY'S HEADLINES PLUS 169 MORE ARTICLES &...
      • HERE'S MONDAY'S HEADLINES PLUS 169 MORE ARTICLES &...
      • HERE'S MONDAY'S HEADLINES PLUS 169 MORE HEADLINES ...
      • A NEW CLASS OF MS DRUGS COMING SOON: protein based...
      • MY Tecfidera update PLUS: WHERE MY JOURNEY BEGAN b...
      • TYSABRI: Elan Corporation bought out by Royalty Ph...
      • I started Tecfidera (BG-12) again on Saturday-. I...
      • I feel Tecifidera drug is working for sure. I want...
      • 18 HEADLINES IN SATURDAY'S NEWS! 2,231 ARTICLES I...
      • 22 MS HEADLINES FROM TODAY'S NEWS FOR DOCS, NURSES...
      • Multiple sclerosis death due to Tecfidera unlikely...
      • 12 HEADLINES FROM TODAYS MS NEWS
      • I'm switching from Avonex to oral Tecfidera
      • MY PHARMACEUTICAL HEAVEN: I'VE TRIED AVONEX, REBIF...
      • I really hate the heat! This heat slurs my words; ...
      • "European green light for new multiple sclerosis m...
      • Biogen Idec Announces Enrollment of First Patient ...
      • Multiple sclerosis death due to Tecfidera unlikely...
      • 12 HEADLINES FROM TODAYS MS NEWS
      • I'm switching from Avonex to oral Tecfidera
      • MY PHARMACEUTICAL HEAVEN: I'VE TRIED AVONEX, REBIF...
      • I really hate the heat! This heat slurs my words; ...
      • "European green light for new multiple sclerosis m...
      • Biogen Idec Announces Enrollment of First Patient ...
  • ►  2013 (22)
    • ►  November (1)
    • ►  October (5)
    • ►  September (5)
    • ►  August (3)
    • ►  July (8)
Simple theme. Powered by Blogger.